We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$89.3B
| $315M | 0.73% |
7,013,658
-1,363,795
| -16% | -$60.7M |
|
|
27
Applied Materials
AMAT
$419B
| $310M | 0.72% |
5,083,305
+4,160,626
| +451% | +$234M |
|
28
Citizens Financial Group
CFG
$30.5B
| $304M | 0.71% |
7,495,295
+67,786
| +0.9% | +$2.54M |
|
29
IBM
IBM
$220B
| $302M | 0.7% |
2,357,001
-637,240
| -21% | -$82.8M |
|
30
TJX Companies
TJX
$179B
| $289M | 0.67% |
4,734,796
-1,404,974
| -23% | -$83.1M |
|
31
KLA
KLAC
$252B
| $254M | 0.59% |
14,258,040
+4,753,380
| +50% | +$79.7M |
|
32
Carnival Corporation Ltd
CCL
$39.4B
| $251M | 0.58% |
4,933,723
+532,475
| +12% | +$23.8M |
|
33
CGI
GIB
$15.4B
| $243M | 0.57% |
2,905,171
+81,749
| +3% | +$6.58M |
|
34
AutoZone
AZO
$50.1B
| $232M | 0.54% |
194,831
-14,498
| -7% | -$16.7M |
|
|
NVO
35
Novo Nordisk
NVO
$203B
| $231M | 0.54% |
7,987,440
-362,022
| -4% | -$10M |
|
36
Morgan Stanley
MS
$336B
| $218M | 0.51% |
4,255,486
-3,502,672
| -45% | -$166M |
|
37
Teradyne
TER
$60.2B
| $215M | 0.5% |
3,155,608
+823,456
| +35% | +$52.3M |
|
38
Cadence Design Systems
CDNS
$93.2B
| $212M | 0.49% |
3,060,772
-654,180
| -18% | -$43.9M |
|
39
Synchrony
SYF
$25.6B
| $209M | 0.49% |
5,805,196
-290,619
| -5% | -$10.4M |
|
40
GSK
GSK
$104B
| $200M | 0.47% |
3,408,956
-586,956
| -15% | -$32.6M |
|
41
Teck Resources
TECK
$32.4B
| $198M | 0.46% |
11,408,016
-2,609
| -0% | -$42.6K |
|
42
HCA Healthcare
HCA
$88.5B
| $195M | 0.45% |
1,316,197
-736,687
| -36% | -$98.9M |
|
43
Veeva Systems
VEEV
$35.4B
| $193M | 0.45% |
1,368,995
+193,318
| +16% | +$28.4M |
|
|
UN
44
DELISTED
Unilever NV New York Registry Shares
UN
| $189M | 0.44% |
3,292,234
-1,251,435
| -28% | -$73.9M |
|
45
Corpay
CPAY
$26B
| $188M | 0.44% |
651,771
-55,175
| -8% | -$16.3M |
|
46
Qualcomm
QCOM
$168B
| $183M | 0.43% |
2,075,506
+1,537,377
| +286% | +$129M |
|
|
CERN
47
DELISTED
Cerner Corp
CERN
| $181M | 0.42% |
2,462,217
-137,792
| -5% | -$9.53M |
|
|
48
NXP Semiconductors
NXPI
$58.4B
| $174M | 0.4% |
1,367,717
+1,305,817
| +2,110% | +$152M |
|
|
KL
49
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $170M | 0.39% |
3,851,523
+2,280,230
| +145% | +$101M |
|
50
MetLife
MET
$64.3B
| $168M | 0.39% |
3,303,725
-257,209
| -7% | -$12.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.